Illumina (ILMN) Smashed 10% On Implied FY11 EPS "Miss"
Tweet
Share
E-mailGet Alerts ILMN Hot Sheet
Price: $207.78 -2.74%
Revenue Growth %: +6.5%
Financial Fact:
Selling, general and administrative: 139.15M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: +6.5%
Financial Fact:
Selling, general and administrative: 139.15M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Illumina Inc. (Nasdaq: ILMN) is trading lower following Q2 results and lackluster guidance.
Illumina reported Q2 EPS of $0.38, $0.01 better than the analyst estimate of $0.37. Revenue for the quarter came in at $287.5 million versus the consensus estimate of $281.62 million.
The company said it sees FY11 non-GAAP EPS of $1.41-$1.44 which is below the consensus of $1.52.
Shares of ILMN are down 9.6%.
Illumina reported Q2 EPS of $0.38, $0.01 better than the analyst estimate of $0.37. Revenue for the quarter came in at $287.5 million versus the consensus estimate of $281.62 million.
The company said it sees FY11 non-GAAP EPS of $1.41-$1.44 which is below the consensus of $1.52.
Shares of ILMN are down 9.6%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Best Buy (BBY) Tops Q2 EPS by 12c, Offers Guidance
- Medtronic jumps on earnings beat and raised guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
